Literature DB >> 23438775

Electromagnetic interference of automatic implantable cardioverter defibrillator and HeartWare left ventricular assist device.

Mohamed R Labedi1, Rami Alharethi, A G Kfoury, Deborah Budge, Reid Bruce, Brad Rasmusson, T Jared Bunch.   

Abstract

The use of continuous-flow left ventricular assist devices (LVAD) have markedly improved outcomes in patients with advanced heart failure (HF). The HeartWare LVAD is a miniaturized centrifugal pump implanted within the pericardial space. Implantable cardioverter-defibrillators (ICDs) are susceptible to oversensing of extracardiac signals (electromagnetic interference [EMI]). We report two cases of EMI in patients that received a HeartWare LVAD as destination therapy for advanced HF. The patients were 75 and 78 years old, both with severe ischemic dilated cardiomyopathy (ejection fraction < 0.20) and New York Heart Association class 4 heart failure. Both patients had a St. Jude Medical Unify ICD with a 7 Fr dual coil St. Jude Medical Durata ICD lead. In both patients, the lead location was in the right ventricular apex with an inferior orientation. Both patients experienced immediate ICD therapies after LVAD placement, requiring the tachytherapies to be disabled. ICD programming changes to increase sensitivity and the detection windows were ineffective. Both patients underwent ICD system revision. In one patient, the existing lead was moved to an anteroseptal location that stopped the EMI. In the other patient, the ICD system was changed to allow a separate right ventricular sensing lead in an anteroseptal location and a dual coil ICD lead placed in an apical location, a strategy used to obtain an acceptable defibrillation threshold. The patients have had no subsequent EMI detected on clinical and remote monitoring. Patients with a right ventricular apical ICD lead placement that undergo placement of a HeartWare LVAD are susceptible to EMI and inappropriate ICD therapies. These cases suggest the primary mechanism is proximity of the ICD lead to the device and as such relocation to an anteroseptal location can overcome the problem. These data suggest that all patients that receive a HeartWare LVAD with an ICD should have the device carefully checked at maximum LVAD output to determine if EMI may be present. ASAIO Journal 2013;59:136-139. Key Words: left ventricular assist device, electromagnetic interference, improper ICD shocks, end-stage heart failure.

Entities:  

Mesh:

Year:  2013        PMID: 23438775     DOI: 10.1097/MAT.0b013e318285fe93

Source DB:  PubMed          Journal:  ASAIO J        ISSN: 1058-2916            Impact factor:   2.872


  4 in total

1.  No Electromagnetic Interference Occurred in a Patient with a HeartMate II Left Ventricular Assist System and a Subcutaneous Implantable Cardioverter-Defibrillator.

Authors:  Ajay Sundara Raman; Farshad Raissi Shabari; Biswajit Kar; Pranav Loyalka; Ramesh Hariharan
Journal:  Tex Heart Inst J       Date:  2016-04-01

2.  Inhibition of pacing in a dependent patient with an implantable cardioverter-defibrillator and a left ventricular assist device.

Authors:  Michele Murphy; Timothy Welch; Peter W Shaw; Jamie L W Kennedy; Kenneth C Bilchick
Journal:  HeartRhythm Case Rep       Date:  2016-07-27

3.  Inappropriate defibrillator shock during gynecologic electrosurgery.

Authors:  Rachel M Kaplan; Jeremiah Wasserlauf; Rachel H Bandi; Elizabeth M Lange; Bradley P Knight; Susan S Kim
Journal:  HeartRhythm Case Rep       Date:  2018-03-26

4.  Effects of thoracic epidural analgesia on plasma cAMP and cGMP levels in patients with heart failure.

Authors:  Qing-Shu Li; Feng-Qi Liu
Journal:  J Cardiothorac Surg       Date:  2013-11-26       Impact factor: 1.637

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.